Detalhe da pesquisa
1.
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Rheumatology (Oxford)
; 61(10): 4155-4162, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108379